AAAAAA
Results:
1-12
|
Results: 12
Authors:
Hejna, M
Kostler, WJ
Raderer, M
Steger, GG
Brodowicz, T
Scheithauer, W
Wiltschke, C
Zielinski, CC
Citation: M. Hejna et al., Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial, EUR J CANC, 37(16), 2001, pp. 1994-2002
Authors:
Kostler, WJ
Brodowicz, T
Attems, Y
Hejna, M
Tomek, S
Amann, G
Fiebiger, WCC
Wiltschke, C
Krainer, M
Zielinski, CC
Citation: Wj. Kostler et al., Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: Results of a phase II trial, ANN ONCOL, 12(9), 2001, pp. 1281-1288
Authors:
Kostler, WJ
Tomek, S
Brodowicz, T
Budinsky, AC
Flamm, M
Hejna, M
Krainer, M
Wiltschke, C
Zielinski, CC
Citation: Wj. Kostler et al., Soluble ICAM-1 in breast cancer: clinical significance and biological implications, CANCER IMMU, 50(9), 2001, pp. 483-490
Authors:
Hejna, M
Hamilton, G
Brodowicz, T
Haberl, I
Fiebiger, WCC
Scheithauer, W
Virgolini, I
Kostler, WJ
Oberhuber, G
Raderer, M
Citation: M. Hejna et al., Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tract, ANTICANC R, 21(2A), 2001, pp. 1183-1187
Authors:
Hejna, M
Kostler, WJ
Tomek, S
Fiebiger, WCC
Raderer, M
Wiltschke, C
Zielinski, CC
Citation: M. Hejna et al., Acceptance of medical information and contentment in cancer patients, WIEN KLIN W, 113(9), 2001, pp. 342-347
Authors:
Kostler, WJ
Hejna, M
Wenzel, C
Zielinski, CC
Citation: Wj. Kostler et al., Oral mucositis complicating chemotherapy and/or radiotherapy: Options for prevention and treatment, CA-A CANC J, 51(5), 2001, pp. 290-315
Authors:
Brodowicz, T
Kostler, WJ
Moslinger, R
Tomek, S
Vaclavik, I
Herscovici, V
Wiltschke, C
Steger, GG
Wein, W
Seifert, M
Kubista, E
Zielinski, CC
Citation: T. Brodowicz et al., Single-agent gemcitabine as second- and third-line treatment in metastaticbreast cancer, BREAST, 9(6), 2000, pp. 338-342
Authors:
Brodowicz, T
Wolfram, RM
Kostler, WJ
Tomek, S
Vaclavik, I
Steger, GG
Teleky, B
Fugger, R
Jakesz, R
Zielinski, CC
Citation: T. Brodowicz et al., Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer, ANTI-CANC D, 11(8), 2000, pp. 623-628
Authors:
Hejna, M
Kostler, WJ
Raderer, M
Tomek, S
Brodowicz, T
Scheithauer, W
Wiltschke, C
Zielinski, CC
Citation: M. Hejna et al., Phase II study of second-line oxaliplatin, irinotecan and mitomycin C in patients with advanced or metastatic colorectal cancer, ANTI-CANC D, 11(8), 2000, pp. 629-634
Authors:
Kostler, WJ
Brodowicz, T
Hejna, M
Wiltschke, C
Zielinski, CC
Citation: Wj. Kostler et al., Detection of minimal residual disease in patients with cancer: A review oftechniques, clinical implications, and emerging therapeutic consequences, CANCER DET, 24(4), 2000, pp. 376-403
Authors:
Wolfram, RM
Budinsky, AC
Brodowicz, T
Kubista, M
Kostler, WJ
Kichler-Lakomy, C
Hellan, M
Kahlhammer, G
Wiltschke, C
Zielinski, CC
Citation: Rm. Wolfram et al., Defective antigen presentation resulting from impaired expression of costimulatory molecules in breast cancer, INT J CANC, 88(2), 2000, pp. 239-244
Authors:
Brodowicz, T
Kostler, WJ
Wiltschke, C
Zielinski, CC
Citation: T. Brodowicz et al., Efficacy of docetaxel in the second-line treatment of locally advanced or metastatic soft tissue sarcoma after failure of chemotherapy with anthracycline or ifosfamide, AM J CL ONC, 22(5), 1999, pp. 535-535
Risultati:
1-12
|